Lessons From Lockdown: Evolving Models of Care for Liver Diseases

Learn important data on the interplay of COVID-19 and viral hepatitis–related liver disease, including COVID-19 outcomes in patients with chronic liver disease (CLD) and expert guidance on clinical management, vaccination, and optimization of telemedicine for patients with CLD during the COVID-19 pandemic.

Robert G. Gish, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit™ Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: January 10, 2022 Expired: No longer available for credit

Key slides on COVID-19 and viral hepatitis–related chronic liver disease (CLD), including COVID-19 outcomes in patients with CLD and expert guidance on clinical management, vaccination, and optimization of telemedicine for patients with CLD during the COVID-19 pandemic.